RGEN: Kapitalisasi marang pendapatan Repligen Corp.
P/S volatility reflects the market valuation of Repligen Corporation (RGEN), where the current metric stands at 13.20. Stability is underpinned by the duplication of bioprocessing consumables production lines. Monopoly influence over filter pricing guarantees high margins due to the complexity of regulatory reviews. Meanwhile, strategic autonomy is maintained by outsourcing routine production to partners while retaining control over patents.
Rincian metrik lan analitis perusahaan Repligen Corp. (RGEN)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- indikator nilai buku ekuitas:
- indikator beban kredit lan likuiditas emiten:
Utang Agregat marang Ekuitas Repligen Corporation|RGEN - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Repligen Inc.|RGEN - Utang perusahaan|Rasio utang marang aset resik Repligen Corp.|RGEN - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Repligen|Rasio likuiditas perantara repligen.com
- data bathi lan kelipatan valuasi:
RGEN - Bathi resik|Prakiraan bathi perusahaan Repligen Corporation|RGEN - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Repligen Corp|RGEN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Repligen Corp.|RGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Repligen|RGEN - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku repligen.com|RGEN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Repligen Corporation
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:repligen.com, RGEN
The P/S ratio reflects the market value of the business per unit of annual revenue, allowing investors to assess the extent of overpayment for assets relative to their ability to generate income. By analyzing changes in the P/S ratio, an investor can observe the market's reaction to financial statements and the intensity of the Repligen Corporation (RGEN) R&D pipeline in bioprocessing and mRNA therapy automation, which determines the fair premium for technological leadership.
Perusahaan pesaing
TEM (Tempus AI) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S QGEN (Qiagen)|IONS - Kapitalisasi marang pendapatan|RNA - Rasio rega marang pendapatan|Rega marang dodolan CRISPR|GeneDx Holdings Corp. (WGS) - Rasio rega marang pendapatan|ultragenyx.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Beam Therapeutics|Sarepta Therapeutics - Rasio rega marang dodolan|Rasio rega marang pendapatan Twist Bio (TWST)|TXG - Rega marang dodolan|Rasio rega marang pendapatan Intellia Therapeutics NTLA|Rasio kapitalisasi pasar marang pendapatan STOK|BioLife Solutions - Multiplikator P/S|WVE - Multiplikator P/S|MAZE (Maze Tx) - Kapitalisasi marang pendapatan|SION: Kapitalisasi marang volume dodolan|PRME (Prime Medicine, Inc.) - Multiplikator P/S|tayshagtx.com (TSHA) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan uniQure (QURE)|MGTX - Rega marang dodolan|Rasio rega marang pendapatan Regenxbio RGNX|SLDB: Rasio kapitalisasi marang pendapatan|OCGN - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PACB (pacb.com)|BNTC: Multiplikator P/S|Multiplikator rega marang pendapatan Design Therapeutics Inc DSGN|RCKT (Rocket Pharmaceuticals Inc) - Multiplikator P/S|Rega marang dodolan 4D Molecular Corp FDMT|Rasio rega marang pendapatan Lexeo Therapeutics (LXEO)|korrobio.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S EDIT (Editas Medicine)|SLN: Rasio kapitalisasi marang pendapatan|PRQR - Rasio rega marang pendapatan|CDXS (Codexis, Inc.) - Rasio kapitalisasi marang pendapatan|SGMO: Multiplikator P/S|Nautilus Bio (NAUT) - Multiplikator P/S|Rasio rega marang pendapatan Metagenomi|DTIL: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S GBIO|BOLD - Rega marang dodolan|Rasio rega marang pendapatan Exicure XCUR|IMNN (Imunon Inc) - Rasio rega marang dodolan|PHIO - Rasio rega marang pendapatan|MBIO: Rasio rega marang pendapatan|RNAZ: Multiplikator P/S|BNGO - Koefisien rega marang pendapatan|APDN (Applied DNA Sciences) - Multiplikator P/S|BLUE - Multiplikator rega marang pendapatan|Multiplikator P/S IPA|OMGA - Rega marang dodolan|Rasio rega marang pendapatan Singular Genomics Systems Inc OMIC|RGLS: Rasio kapitalisasi marang pendapatan|SYRS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan TBIO (telesisbio.com)|TCON: Multiplikator P/S|Kapitalisasi marang pendapatan Unity Biotechnology Inc.
